Bauer, Todd M.
Shaw, Alice T.
Johnson, Melissa L.
Navarro, Alejandro
Gainor, Justin F.
Thurm, Holger
Pithavala, Yazdi K.
Abbattista, Antonello
Peltz, Gerson
Felip, Enriqueta
Funding for this research was provided by:
Pfizer Inc.
Article History
First Online: 14 February 2020
Compliance with Ethical Standards
:
: This study was sponsored by Pfizer Inc.
: TMB has received fees for consulting/advisory board roles for Guardant Health, Ignyta, Loxo, Moderna Therapeutics, and Pfizer Inc. ATS has received fees for consulting/advisory board roles from Ariad/Takeda, Bayer, Blueprint Medicines, Chugai, Daiichi Sankyo, EMD Serono, Genentech, Ignyta, KSQ Therapeutics, Loxo, Natera, Novartis, Pfizer, Roche, Taiho, and TP Therapeutics, and honoraria from Foundation Medicine, Guardant, Novartis, Pfizer, and Roche. AN has received fees for consult/advisory board roles from Boehringer Ingelheim, Roche, Pfizer, Bristol-Myers Squibb, Oryzon Genomics and travel expenses from Pfizer and Boehringer Ingelheim. MLJ has nothing to disclose. JFG has received fees for consulting/advisory board roles from Bristol-Myers Squibb, Genentech/Roche, Novartis, Loxo, Theravance, Clovis, Merck, Boehringer Ingelheim, and Incyte. HT, GP, YKP, and AA own stock in and are employees of Pfizer. EF has received fees for consulting/advisory board roles for Celgene, Eli Lilly, Guardant Health, and Takeda, and has served as a consultant and on the speakers’ bureau for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, Pfizer, and Roche.